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Research Article

Differential mechanisms of Cantú syndrome–associated gain of
function mutations in the ABCC9 (SUR2) subunit of the KATP channel
Paige E. Cooper,1,2* Monica Sala-Rabanal,1,2* Sun Joo Lee,1,2 and Colin G. Nichols1,2
Department of Cell Biology and Physiology, and 2Center for the Investigation of Membrane Excitability Diseases, Washington
University School of Medicine, Saint Louis, MO 63110

Cantú syndrome (CS) is a rare disease characterized by congenital hypertrichosis, distinct facial features, osteochondrodysplasia, and cardiac defects. Recent genetic analysis has revealed that the majority of CS patients carry a
missense mutation in ABCC9, which codes for the sulfonylurea receptor SUR2. SUR2 subunits couple with Kir6.x,
inwardly rectifying potassium pore-forming subunits, to form adenosine triphosphate (ATP)-sensitive potassium
(KATP) channels, which link cell metabolism to membrane excitability in a variety of tissues including vascular
smooth muscle, skeletal muscle, and the heart. The functional consequences of multiple uncharacterized CS mutations remain unclear. Here, we have focused on determining the functional consequences of three documented
human CS-associated ABCC9 mutations: human P432L, A478V, and C1043Y. The mutations were engineered in
the equivalent position in rat SUR2A (P429L, A475V, and C1039Y), and each was coexpressed with mouse Kir6.2.
Using macroscopic rubidium (86Rb+) efflux assays, we show that KATP channels formed with P429L, A475V, or
C1039Y mutants enhance KATP activity compared with wild-type (WT) channels. We used inside-out patch-clamp
electrophysiology to measure channel sensitivity to ATP inhibition and to MgADP activation. For P429L and A475V
mutants, sensitivity to ATP inhibition was comparable to WT channels, but activation by MgADP was significantly
greater. C1039Y-dependent channels were significantly less sensitive to inhibition by ATP or by glibenclamide, but
MgADP activation was comparable to WT. The results indicate that these three CS mutations all lead to overactive
KATP channels, but at least two mechanisms underlie the observed gain of function: decreased ATP inhibition
and enhanced MgADP activation.
INTRODUCTION

ATP-sensitive potassium (KATP) channels, found in many
excitable tissues, including brain (Ashford et al., 1988),
heart (Noma, 1983), pancreatic islets (Cook and Hales,
1984), and skeletal and smooth muscle (Standen et al.,
1989; Winquist et al., 1989) are hetero-octameric protein
complexes composed of four pore-forming inwardly
rectifying potassium channel Kir6.X subunits, each associated with one sulfonylurea receptor subunit (SURX)
(Shyng and Nichols, 1997). KATP channels link cell metabolism with membrane excitability as a result of intracellular nucleotide regulation of channel activity. ATP
binds directly to the pore-forming Kir6.X subunits
(Tucker et al., 1997) to inhibit the channel, and MgADP
binds to SURX to activate the channel (Nichols et al.,
1996). Channels formed from different combinations of
Kir6.1 (KCNJ8), Kir6.2 (KCNJ11) (Inagaki et al., 1995a,b),
SUR1 (ABCC8), and SUR2 (ABCC9) subunit isoforms
vary in nucleotide sensitivity and pharmacology (Masia
et al., 2005), as well as tissue localization (Aguilar-Bryan
et al., 1995; Inagaki et al., 1996), generating additional
*P.E. Cooper and M. Sala-Rabanal contributed equally to this paper.
Correspondence to Colin G. Nichols: cnichols@wustl.edu
Abbreviations used in this paper: CS, Cantú syndrome; GOF, gain of
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functional diversity of KATP channels (Nichols, 2006;
Akrouh et al., 2009).
Cantú syndrome (CS) was first recognized as a unique
disorder in 1982 (Cantú et al., 1982). Clinical hallmarks
of CS include hypertrichosis, macrosomia, macrocephaly, coarse facial appearance, cardiomegaly, and skeletal
abnormalities (Harakalova et al., 2012; van Bon et al.,
2012; Cooper et al., 2014). Recent studies have shown
that the majority of known CS patients have missense
mutations in ABCC9 (Harakalova et al., 2012; van Bon
et al., 2012) or KCNJ8 (Brownstein et al., 2013; Cooper
et al., 2014) that result in a gain of function (GOF) in
KATP channel activity. CS resulting from mutations in
either subunit confirms that functional changes in the
KATP channels formed from them underlie the disease.
Conversely, KCNJ11 and ABCC8, which encode Kir6.2
and SUR1, respectively, generate KATP channels in pancreatic  cells (Inagaki et al., 1995a), and GOF mutations
in either of these subunits give rise to neonatal diabetes
mellitus (NDM) (Gloyn et al., 2004; Babenko et al.,
2006), characterized by decreased insulin secretion and
elevated blood glucose levels. Detailed analyses of NDM
© 2015 Cooper et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication
date (see http://www.rupress.org/terms). After six months it is available under a Creative
Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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Figure 1. CS mutations in SUR2. (A) Alignment of SUR2 (ABCC9) with the multidrug ABC transporter Sav1866 (2ONJ) and heterodimeric ABC transporter TM287-TM288 (3QF4), upon which we built homology models. (B and C) Key structural domains TMD1 and 2
and NBD1 and 2 are indicated, as well as predicted -helical (pink) and -strand (green) segments. (B) Homology models of “open” and
“closed” conformations of the SUR2A protein, which are based on Staphylococcus aureus Sav1866, a bacterial homologue of the human
ABC transporter Mdr1 and heterodimeric ABC transporter TM287-TM288 (TM287/288) from Thermotoga maritime, respectively. Published CS mutations from previous reports are shown in green (open) and light pink (closed).
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mutations in ABCC8 demonstrate that distinct molecular
mechanisms can underlie the increase in channel activity, including increased open probability (Po) (Koster

et al., 2005; Babenko et al., 2006; Proks et al., 2007) and
increased MgADP activation (de Wet et al., 2007b; Masia
et al., 2007). To understand the molecular mechanisms

KATP conductance is increased in basal
and stimulated conditions in intact cells expressing
homomeric P429L and A475V-based KATP channels.
(A–D) Rate constants for KATP-dependent 86Rb+ efflux (k1 in gray, proportional to nonspecific K+ conductance and k2, proportional to KATP-specific K+
conductance) were calculated from data shown in
Fig. 2. *, P < 0.05 as compared with WT (unpaired
Student’s t test). Error bars represent mean ± SEM.
Figure 3.
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Figure 2. Increased channel activity in intact
cells expressing homomeric P429L-, A475V-,
or C1039Y-containing KATP channels. 86Rb+
efflux as a function of time was measured in
GFP-transfected control cells (dashed) and
in cells transiently expressing reconstituted
Kir6.2-based KATP channels with WT, P429L,
A475V, or C1039Y SUR2 subunits in homomeric configuration, in basal conditions (A),
in the presence of MIs oligomycin and 2-deoxy-d-glucose (B), in the K+ channel opener
PIN (C), or in the presence of both MI and
PIN (D). The data represent means ± SEM of
6–10 experiments. Flux data were fit with Eq. 1
(GFP) to obtain the rate constant k1 or Eq. 2
to obtain the rate constants for KATP-dependent efflux, k2 (Fig. 3), where lines show mean
fitted relationships.

Published November 30, 2015

of CS-associated ABCC9 mutations, we have engineered
and analyzed channel properties for three CS mutations
that localize to different regions of the protein: P429L,
A475V, and C1039Y. Given the experimental difficulty
of recording Kir6.1/SUR2 currents (Cooper et al., 2014),
we studied Kir6.2+SUR2A channels in the present experiments, and by means of 86Rb+ efflux assays in intact
cells transiently transfected with WT or mutant subunits, we confirm that all three mutations result in overactive KATP channels. Consistent with the diversity of
mechanisms found in NDM patients with ABCC8 mutations, we further show that CS-associated ABCC9 GOF
mutations can result from at least two different mechanisms: decreased sensitivity to inhibition by ATP or enhanced channel activation by MgADP.

Homology modeling
Models of human SUR2A (Fig. 1) were built using Modeller v9.8
from the template of the multidrug ABC transporter Sav1866

T a ble 1

Rate constants for homomeric fluxes
Condition
Basal
k1
GFP
k2
SUR2A-WT
P429L
A475V
C1039Y
k1
GFP

Mean

SEM

n

0.017

0.001

11

0.001
0.004
0.004
0.003

0.000
0.001
0.001
0.001

11
8
8
8

0.029

0.001

0.000

0.000

0.026

0.005

9

0.043
0.089
0.098
0.015

0.007
0.016
0.014
0.007

9
6
6
7

0.068

0.010

0.006

0.006

0.018

0.001

6

0.016
0.052
0.060
0.005

0.002
0.010
0.005
0.001

6
4
4
4

0.028

0.002

0.009

0.002

0.016

0.007

6

0.101
0.097
0.125
0.013

0.033
0.024
0.030
0.007

7
7
7
8

0.029

0.001

0.074

0.014

k2
MI
k1
GFP
k2
SUR2A-WT
P429L
A475V
C1039Y
k1
GFP
k2
PIN
k1
GFP
k2
SUR2A-WT
P429L
A475V
C1039Y
k1
GFP
k2

Figure 4. Relative KATP conductance is markedly increased in
basal and stimulated conditions in intact cells expressing homomeric C1039Y KATP channels. (A–C) The ratio of the rate constants for KATP-dependent 86Rb+ efflux (k2) in basal and PIN- or
MI-stimulated conditions to the maximal activation (in MI+PIN)
is plotted for WT and mutant channels. *, P < 0.05 as compared with WT (unpaired Student’s t test). Error bars represent
mean ± SEM.
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MI+PIN
k1
GFP
k2
SUR2A-WT
P429L
A475V
C1039Y
k1
GFP
k2
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MATERIALS AND METHODS

(2ONJ, to model the “open” conformation) and heterodimeric
ABC transporter TM287-TM288 (3QF4, to model the “closed” conformation), respectively. The TM0 domain and L0 loop (1–281)
were omitted because of lack of sequence homology to any proteins of known structure. Two extended loops unique to SUR2A
were also omitted: one connecting TM1 and NBD1 (614–672)
and a second connecting NBD1 and TM2 (920–966). A multiple

Published November 30, 2015

sequence alignment (MSA) was performed using ClustalW2 between SUR2 and the two template sequences in conjunction with
other proteins of the human ABCC family (ABCC1, 2, 3, 4, 5, 6, 8,
and 10) for TM1 and NBD1 because of low sequence identity.
High sequence identity enabled a reliable sequence alignment
of TMD2 and NBD2 by MSA between SUR2 and SUR1, 2ONJ,
and 3QF4.

Macroscopic 86Rb+ efflux assays
Cells were incubated overnight at 37°C in DMEM containing
1 µCi/ml 86RbCl (PerkinElmer), and then incubated in Ringer’s
solution (mM: 118 NaCl, 10 HEPES, 25 NaHCO3, 4.7 KCl, 1.2
KH2PO4, 2.5 CaCl2, and 1.2 MgSO4, adjusted to pH 7.4 with
NaOH) in (a) the absence (basal) or (b) the presence of 2.5 mg/ml
oligomycin and 1 mM 2-deoxy-d-glucose (metabolic inhibition
[MI]), (c) the SUR2-specific K+ channel opener pinacidil (PIN;
250 µM), or (d) a combination of MI and PIN to achieve maximal
channel activation. Subsequently, at selected time points (2.5, 5,
7.5, 15, 25, and 40 min) the solution was collected and replaced
with fresh solution. Upon completion of the assay, cells were lysed
with 2% SDS and collected, and radioactivity in these samples was
measured by liquid scintillation. 86Rb+ efflux is expressed as a fraction of total content. A nonspecific efflux that inactivated with
time was assumed to be present in all 86Rb+ efflux experiments,
and apparent rate constants for the KATP-independent 86Rb+ efflux
were obtained from GFP-transfected cells using the equation:
Rb efflux = 1 − exp −k1 *e

( − k−1 *t ) .t

,

(1)

where k1 and k1 are the apparent activation and inactivation
rate constants. KATP-dependent 86Rb+ efflux was also assumed to

ATP sensitivity is decreased in C1039Y
channels. Representative excised patch-current
recordings from COSm6 cells coexpressing Kir6.2
and WT or CS mutant SUR2 subunits P429L,
A475V, or C1039Y (A). Membrane potential was
held at 50 mV, and negative currents (plotted as
upward deflections) were recorded continuously
on-cell and in inside-out excised patches exposed
to KINT in the absence or presence of 0.01, 0.1, or
1 mM ATP; arrowheads mark the point of excision. (B) Dose–response data (mean ± SEM from
8–11 patches) was fit with Eq. 3 to estimate the
ATP concentration for half-maximal inhibition
Ki: WT (9 µM), P429L (9 µM), A475V (7 µM),
and C1039Y (21 µM). (C) Maximum patch-current immediately after patch excision (mean ±
SEM from 8–11 patches). *, P < 0.05 as compared
with WT (unpaired t test). Error bars represent
mean ± SEM.

Figure 5.
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ABCC9 mutagenesis and heterologous expression
of KATP channels
The Quick Change II Site-Directed Mutagenesis kit (Agilent Technologies) was used to engineer P429L, A475V, and C1039Y mutations (equivalent to CS-associated P432L, A478V, and C1043Y
mutations in human SUR2; Harakalova et al., 2012; van Bon et al.,
2012) into rat SUR2A-pCMV6. Mutations were confirmed by direct sequencing of the entire SUR2A coding region. For channel
expression, COSm6 cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum, 105 U/L penicillin, and 100 mg/L streptomycin. At 60–
70% confluence, cells were transfected with the relevant plasmids
using FuGENE6 transfection reagent (Promega). For experiments with homomeric CS mutant channels, cells were cotransfected with pCDNA3.1-mKir6.2-WT (0.6 µg) and WT or mutant
pCMV6-ratSUR2A (SUR2) (1 µg). For experiments using heteromeric channels, cells were cotransfected with Kir6.2-WT, SUR2-WT,
and mutant SUR2 at ratios of 0.6:0.5:0.5 (w/w/w). Cells transfected with GFP-pcDNA3.1 served as controls. A small amount of

GFP DNA was coexpressed for identification of transfected cells
in electrophysiology experiments.

Published November 30, 2015

activate and inactivate with time and was obtained using
the equation:

Rb efflux = 1 − exp

( − k *t ) 

− k *t
−  k1 *e ( −1 ) + k2 *e −2 ⋅t 



,

(2)

where k1 and k1 are the rate constants for KATP-independent
pathways (obtained from GFP-transfected cells by Eq. 1), and k2
and k2 are the activation (k2) and inactivation (k2) rate constants for KATP-specific K+ conductance. k2 is then assumed to be
proportional to the number of active channels. To account for
potential day-to-day variability, for every efflux experiment, a k1
value was determined for untransfected cells and then incorporated as a fixed parameter in the equation to estimate the
KATP-dependent k2 for each construct. All k values are listed
in Tables 1–3.

Excised patch clamp
After 24–48 h, transfected cells that fluoresced green under UV
light were selected for analysis by excised patch-clamp experiments at room temperature in a perfusion chamber that allowed
for the rapid switching of solutions. Kint solution (mM: 140 KCl,
10 HEPES, and 1 EGTA, pH 7.4) was used as the standard pipette
(extracellular) and bath (cytoplasmic) solution in these experiments. ATP or ADP was added as indicated. The appropriate
amounts of MgCl2 to be added in each Mg2+-nucleotide–containing solution to attain 0.5 mM of free Mg2+ were calculated by
means of the CaBuf program (Katholieke Universiteit Leuven).
Membrane patches were voltage clamped using an Axopatch 1D
amplifier (Molecular Devices), and currents were recorded at
50 mV (pipette voltage, 50 mV) in on-cell and inside-out excised
patch configuration. Data were typically filtered at 1 kHz and digitized at 5 kHz with a Digidata 1322A (Molecular Devices) A-D
converter. pClamp and Axoscope software (Molecular Devices)

Downloaded from jgp.rupress.org on December 19, 2015
C1039Y channels decreased ATP sensitivity caused by increased Po. (A) Representative
KATP current traces after excision and in the presence of 1 mM ATP or 5 µg/µl PIP2 as indicated.
(B) Relative Po determined as a ratio of the maximum steady-state current in the patch upon excision,
in the absence of nucleotides over the maximum
current measured in PIP2. Individual patch data are
represented by symbols (n = 7–10); error bars are the
means ± SEM, respectively relative to Po = 0.70 ±
0.11 (WT) and 1.26 ± 0.21 (C1039Y). *, P < 0.05 as
compared with WT (unpaired Student’s t test).
Figure 6.
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were used for data acquisition. For ATP inhibition, [ATP]-response
relationships (Fig. 4) were fitted by Eq. 3:
−1

  [ ATP ] H 
I rel = 1 + 
  ,
Ki  

 

(3)

where Irel (relative current) is the current in the presence of a given
concentration of ATP relative to current in zero ATP, Ki is the apparent ATP inhibition constant, and H is the Hill coefficient.
For phosphatidylinositol (4,5)-bisphosphate (PIP2) activation
experiments, an ammonium salt of l--phosphatidylinositol-4,5bisphosphate from porcine brain (Brain PI(4,5)P2; Avanti Polar
Lipids, Inc.) was dissolved in KINT to make a 5-µg/µl working solution. For each patch, we estimated the relative Po by dividing the
maximum steady-state current in zero ATP by the maximum steadystate current in PIP2.

RESULTS

CS-associated mutations have been found throughout
the coding sequence (Fig. 1). For the present study, we focused on two previously unexamined mutations (human
A478V and C1043Y corresponding to rat A475V and

Figure 7. P429L and A475V show enhanced
MgADP activation. (A) Representative KATP
current traces after excision and in the presence of nucleotides as indicated. (B) MgADP
activation, as a ratio between the steady-state
current in the presence of MgADP and the
maximum current measured in the patch
upon excision, in the absence of nucleotides.
Individual patch data represented by symbols
(n = 11–24); error bars are the means ± SEM,
respectively 26.8 ± 0.03% (WT), 56.9 ± 0.06%
(P429L), 59.7 ± 0.1% (A475V), and 38.7 ±
0.04% (C1039Y). *, P < 0.05 as compared with
WT (unpaired Student’s t test). Inset shows
the mean current measured in patches in the
presence of 0.1 mM of Mg-free ATP (from
Fig. 5 B) subtracted from the mean value of
steady-state current measured in patches in
the presence of MgADP (from Fig. 7 A). Error
bars represent the propagated error from
both experiments. (C) Half-time of activation
by MgADP.
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Homomeric mutant channels are overactive in various
metabolic conditions

C1039Y, respectively), located in the TMD1 and TMD2
segments, and P432L (corresponding to rat P429L),
also located in the TMD1 region. To examine KATP channel activity in intact cells, we performed 86Rb+ efflux assays under four different conditions: basal, MI, in the
presence of PIN, and MI and PIN combined (MI+PIN).
As shown in Figs. 2 and 3, homomeric expression of
SUR2A-P429L, A475V, or C1039Y channels, results in a
significantly higher basal 86Rb+ efflux rate compared
with WT (Figs. 2 A and 3 A). P429L- and A475V-based
channels, but not those composed of C1039Y, also
showed a significantly higher rate of efflux compared
with WT channels under MI conditions and in the presence of PIN (Figs. 2, B and C, and 3, B and C), consistent
with the GOF observed in the basal condition. Maximal
efflux rates (estimated using simultaneous exposure to
MI and PIN) of P429L and A475V were comparable to
SUR2A-WT, implying similar channel densities at the
cell surface (Figs. 2 D and 3 D). C1039Y showed significantly lower absolute fluxes in all stimulatory conditions
(Figs. 2, B–D, and 3, B–D), implying a lower channel
density at the membrane (Fig. 4).
The ratio of KATP-dependent (k2) rate constants in
basal, MI, and PIN to the maximal KATP-dependent rate

Published November 30, 2015

constant (in MI+PIN) should reflect the relative activation of each channel in these specific conditions. In the
basal condition, the ratio was higher for all three mutations than for WT, markedly so for C1039Y (Fig. 4 A). In

C1039Y (hC1043Y) overactivity results from enhanced
open-state stability and decreased ATP sensitivity

T a ble 2

Rate constants for heteromeric fluxes
Condition

k1
GFP

86

Mean

SEM

n

0.019

0.001

8

0.001
0.001
0.001
0.001

0.000
0.000
0.001
0.000

8
3
3
3

0.029

0.001

0.000

0.000

0.027

0.005

8

0.044
0.040
0.047
0.017

0.007
0.009
0.010
0.003

8
3
3
3

0.068

0.010

0.006

0.006

0.018

0.002

5

0.017
0.022
0.026
0.007

0.002
0.004
0.005
0.000

5
4
4
4

0.028

0.002

0.009

0.002

0.019

0.003

4

0.091
0.077
0.096
0.047

0.004
0.002
0.007
0.002

4
3
3
4

0.029

0.001

0.074

0.014

k2
MI
k1
GFP
k2
SUR2A-WT
P429L
A475V
C1039Y
k1
GFP
k2
PIN
k1
GFP
k2
SUR2A-WT
P429L
A475V
C1039Y
k1
GFP
k2
MI+PIN
k1
GFP
k2
SUR2A-WT
P429L
A475V
C1039Y
k1
GFP
k2
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Rb+ flux assays provide evidence for overactivity in CS
mutants, but do not provide any indication of underlying molecular mechanisms. We assessed the details of
channel properties in inside-out excised patch-clamp
electrophysiology experiments. Intrinsic sensitivity to
ATP inhibition (in zero Mg2+) was similar for WT, P429L,
and A475V channels (Ki = 7–9 µM). However, KATP channels expressing C1039Y exhibited a significant right
shift in ATP sensitivity (Ki = 21.3 µM; Fig. 5 B). A diminished sensitivity to intracellular ATP may account, at
least in part, for the increased activity of C1039Y-based
KATP channels in basal conditions in the intact cell
(Figs. 2 A and 3 A). Consistent with reduced channel
density, the maximal current in zero ATP was significantly lower in C1039Y channels than in WT, P429L, or
A475V channels (Fig. 5 C). The Po in the absence of inhibitory ATP (zero) was estimated by the application of
PIP2 (Koster et al., 2005). After the application of PIP2,
both WT and C1039Y channels lost ATP sensitivity; however, the current in zero ATP increased for WT channels but not for C1039Y channels (Fig. 6). The ratio
of the initial maximum current in zero ATP to that in
PIP2 (WT: 0.70 ± 0.11 vs. C1039Y: 1.26 ± 0.21) reflects
marked increase in WT maximum Po but no increase
for C1039Y.
Overactivity in P429L (hP432L) and A475V (hA478V) results
from increased MgADP activation

We investigated the current response to intracellular
MgADP in the presence of 0.1 mM ATP (Fig. 7 A).
MgADP-dependent activation was estimated as the ratio
between the steady-state activated current in MgADP+ATP
and the maximal current in zero ATP, immediately
after excision (Fig. 7 B). The relative current in MgADP
was markedly higher than WT for P429L and A475V
channels. Using this analysis, the current was also statistically higher for C1039Y channels. However, this analysis ignores the intrinsically lower sensitivity of C1039Y
channels to ATP inhibition (Fig. 5 C). An alternative
estimation for the stimulatory action of Mg nucleotides
is to calculate the ratio of current in MgADP+ATP to that
in Mg-free ATP alone (Fig. 7 B, inset). This analysis implies no difference in the MgADP activation of C1039Y
and WT channels. In addition, although the MgADP
activation for P429L and A475V channels is more rapid
than WT, activation of the C1039Y channel is even slower
than WT (Fig. 7 C).

Downloaded from jgp.rupress.org on December 19, 2015

Basal
k1
GFP
k2
SUR2A-WT
P429L
A475V
C1039Y

PIN alone, although only P429L and A475V reach significance, the ratio of active channels in all three mutations
are also increased (Fig. 4 C). Collectively, the results
suggest that each mutant will result in higher channel
activation under any stimulatory conditions, particularly
for C1039Y.

Published November 30, 2015

GOF is reduced in heteromeric mutant channels

All documented CS patients with mutations in ABCC9
are heterozygous. To mimic the predicted heteromeric
composition of channels in such patients, we also expressed each mutation in a 1:1 ratio with SUR2A-WT
plus Kir6.2, and assessed channel activity by 86Rb+ efflux
assays (Figs. 8 and 9). In all conditions, P429L, A475V,
and C1039Y heteromeric channels display no significant increases in the rate of 86Rb+ efflux compared with
WT channels (Figs. 8 A and 9 A). When normalized to
the maximal efflux rates, channels with heteromeric expression of C1039Y are still considerably less active than
WT. In the heteromeric state, maximal C1039Y channel
fluxes were markedly higher than in the homomeric
state (Fig. 9 D), also implying a partial rescue of the

surface expression of C1039Y subunits by WT subunits
(Figs. 8, B–D, and 9, B–D).
Altered response to glibenclamide in C1039Y channels

Some NDM patients with GOF mutations in Kir6.2 or
SUR1 have successfully been switched from insulin therapy to KATP inhibitors such as glibenclamide (Zung
et al., 2004). However, a correlation between increased
channel activity and diminished effectiveness of such
drugs has been noted (Koster et al., 2005). Therefore,
to test the effectiveness of glibenclamide on overactive
P429L, A475V, or C1039Y channels, expressed both homomerically and heteromerically; 86Rb+ efflux experiments were performed in the presence of MI plus 10 µM
glibenclamide (Fig. 10). The time course of Rb+ effluxes

Downloaded from jgp.rupress.org on December 19, 2015

Channel activity in cells expressing heteromeric P429L-, A475V-, or C1039Y-based KATP channels. 86Rb+ efflux as a function of
time was measured in GFP-transfected control cells (dashed) and in cells transiently expressing reconstituted Kir6.2-based KATP channels
with WT or 1:1 mixtures of WT and P429L, A475V, or C1039Y mutant SUR2 subunits in basal conditions (A), in the presence of MIs
oligomycin and 2-deoxy-d-glucose (B), in the K+ channel opener PIN (C), or in the presence of both MI and PIN (D). The data represent
means ± SEM of 6–10 experiments. Flux data were fit with Eq. 1 (GFP) to obtain the rate constant k1 or Eq. 2 to obtain the rate constants
for KATP-dependent efflux, k2 (Fig. 3), where lines show mean fitted relationships.
Figure 8.
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for SUR1 mutations that produce increased activity of
resultant KATP channels.
DISCUSSION
Distinct mechanisms of KATP GOF in CS ABCC9 mutations

CS is a rare disease characterized by complex vascular
and skeletal anomalies, the underlying cellular and molecular mechanisms of which we are only now beginning to understand (Nichols et al., 2013). The majority
of genotyped CS patients are heterozygous for mutations in the genes encoding ABCC9 (SUR2) (Harakalova
et al., 2012; van Bon et al., 2012) in most cases, and
KCNJ8 (Kir6.1) (Brownstein et al., 2013; Cooper et al.,
2014) in others. A select few of these mutations have
thus far been shown to form overactive KATP channels
(Harakalova et al., 2012; Cooper et al., 2014), and most
remain unexplored. Here, we characterized three CSassociated ABCC9 mutations, namely P429L (hP432L),
A475V (hA478V), and C1039Y (hC1043Y), that localize

Figure 9. KATP conductance normalized in basal and stimulated conditions in heteromeric P429L-, A475V-, or C1039Y-based KATP channels. (A–D) The rate constants for nonspecific efflux (k1 represented by gray area) and KATP-dependent 86Rb+ efflux (k2), proportional
to KATP-specific K+ conductance, were estimated from data shown in Fig. 7. Error bars represent mean ± SEM.
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shows an unusual behavior in that although initial fluxes
are markedly lower than in MI alone, the inhibition is
not maintained through the time course of the assay. It
is well understood that the inhibitory action of glibenclamide is a complex function of the metabolic conditions and decreases under conditions of MI (Findlay,
1994; Koster et al., 1999). To account for this behavior,
the efflux data in glibenclamide were fit by Eq. 2, where
positive values for k2 now result in the rate of efflux
actually increasing with time for A475V and P429L channels (see Table 3). From this analysis, the ratio of the k2
in MI plus glibenclamide to k2 in MI provides an estimate
of the relative sensitivity to inhibition by glibenclamide
(Fig. 10 C). Although the glibenclamide sensitivity of
A475V and P429L channels was not different from WT,
C1039Y channels appeared almost insensitive to the
drug. Qualitatively similar results were obtained with
channels expressed in heteromeric mixture with WT
subunits (Fig. 10, B–D). As discussed below, this glibenclamide insensitivity is consistent with similar findings

Published November 30, 2015

T a ble 3

Rate constants for fluxes in MI+GLIB
Condition
MI+GLIB
k1
GFP
k2
SUR2A-WT
P429L
A475V
C1039Y
hetP429L
hetA475V
hetC1039Y
MI+GLIB
k1
GFP

Mean

SEM

n

0.020

0.004

7

0.004
0.005
0.005
0.007
0.003
0.005
0.004

0.001
0.003
0.001
0.002
0.001
0.000
0.001

7
4
6
6
3
3
3

0.009

7

0.047

0.008

7

P429L

0.039

0.028

4

A475V

0.045

0.010

4

C1039Y

0.003

0.013

6

hetP429L

0.030

0.010

3

hetA475V

0.042

0.006

3

hetC1039Y

0.031

0.010

3

MI+GLIB, MI plus glibenclamide.

to distinct regions of the SUR2 protein (Fig. 1). Each
mutation leads to KATP channel GOF (Figs. 2–7), consistent with previous findings on isolated CS-associated
ABCC9 mutations (Harakalova et al., 2012).

Figure 10. Decreased sensitivity to glibenclamide inhibition in C1039Y channels. 86Rb+
efflux as a function of time was measured in
GFP-transfected control cells and in cells transiently expressing KATP channels composed of
Kir6.2 plus WT or mutant SUR2 subunits (A),
as well as in cells expressing a 1:1 mixture of WT
and mutant SUR2 subunits. (B) Experiments
were performed in MI plus glibenclamide. The
data represent the means ± SEM of three to six
experiments. Data were fit with Eq. 2 to obtain
rate constants for KATP-dependent efflux, k2.
(C and D) k2 in glibenclamide plus MI divided
by k2 in MI for each condition.
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0.053

k2
SUR2A-WT

In the only previous assessment of CS-associated ABCC9
mutations, Harakalova et al. (2012) measured channel
sensitivity to ATP in the presence of Mg2+. Mg nucleotides have complex activatory/inhibitory effects on KATP
channels: MgATP can both inhibit the Kir6.X subunit
and be hydrolyzed to activatory MgADP at the SUR subunits (Nichols, 2006). Therefore, such an analysis cannot
separate mutant effects on ATP inhibition from those on
Mg nucleotide activation. By separately assessing channel
activity in response to Mg-free ATP and to MgADP, we
show that CS-associated ABCC9 mutations lead to increased
channel activity via different mechanisms, as has also
been observed with NDM-associated ABCC8 mutations
(de Wet et al., 2007a, 2008; Masia et al., 2007; Zhou et al.,
2010). Specifically, we demonstrate that increased activity of P429L and A475V channels results from increased
MgADP activation, whereas increased activity of C1039Y
channels results predominantly from decreased ATP
sensitivity caused by higher intrinsic open-state stability.
Some NDM-causing GOF mutations in SUR1 have also
been shown to reduce ATP sensitivity (Tarasov et al.,
2008; Takagi et al., 2013), either by reducing inhibitory
ATP-binding affinity or by increasing the intrinsic openstate stability of the channel (Shyng and Nichols, 1998;
Koster et al., 2005). That PIP2 decreases ATP sensitivity,
but does not increase maximum currents, in the C1039Y
channel implies that the intrinsic Po of these channels is
near 1 (relative Po = 1.26 ± 0.21), significantly higher
than for WT channels (relative Po = 0.70 ± 0.11; Fig. 6),
explaining the intrinsically lower ATP sensitivity of the
C1039Y channel.
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In addition to increasing channel activity, homomeric
expression of C1039Y appears to decrease expression of
channels in the membrane, detectable in both 86Rb+
flux and patch-clamp analyses. A similar dual effect of
GOF mutations in both Kir6.2 (Lin et al., 2013) and
SUR1 (Zhou et al., 2010) has been shown previously. In
these previous examples, decreased surface expression
was demonstrated by Western blot analysis. Significant
rescue of channel activity in heteromeric C1039Y/WT
channels is consistent with the patterns from such mutations (Figs. 8 and 9); therefore, we suggest that in addition to reducing ATP sensitivity of expressed channels,
C1039Y also decreases KATP surface expression.
Implications for tissue pathology in CS

Implications for therapeutic intervention in CS

Finally, sulfonylureas, which inhibit KATP channels via
interaction with the SUR subunits, are effective treatments for NDM patients with ABCC8-activating mutations
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